Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 20/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL899069 | 1.00 | FDPS (0.41) | FDPS | |
| SCHEMBL617158 | 1.00 | FDPS (0.41) | FDPS | |
| SCHEMBL1773792 | 0.97 | FDPS (0.41) | FDPS | |
| Phosphoric Acid SCHEMBL5449030 | 0.95 | FDPS (0.43) | FDPS | |
| SCHEMBL669819 | 0.94 | FDPS (0.43) | FDPS | |
| SCHEMBL6264031 | 0.94 | FDPS (0.43) | FDPS | |
| SCHEMBL4486157 | 0.94 | FDPS (0.43) | FDPS | |
| SCHEMBL4489691 | 0.94 | FDPS (0.43) | FDPS | |
| SCHEMBL28904337 | 0.94 | FDPS (0.43) | FDPS | |
| SCHEMBL28390378 | 0.94 | FDPS (0.43) | FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118165479-A | Antistatic laser film and preparation method thereof | 杭州梅清数码科技有限公司 | 2024-06-11 | — | — | CN | disclosed |
| US-6410799-B1 | LIQUID PHASE HEATING | INSTITUT FRANCAIS DU PETROLE (FR) | 2002-06-25 | — | — | US | disclosed |
| US-20020035297-A1 | Hydroformylation process employing a catalyst based on cobalt and/or rhodium in a non-aqueous ionic solvent | INSTITUT FRANCAIS DU PETROLE (FR) | 2002-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035297-A1 | Hydroformylation process employing a catalyst based on cobalt and/or rhodium in a non-aqueous ionic solvent | NUDT1, IDH1, HRH4 | FDPS 621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.